4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000052
President CEO and Chairman sold 81,007 shares at an average $133.36 ($10,802,803)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R President CEO and Chairman | 2024-03-12 | Sale 10b5-1 | −29,675 | $134.41 | $3,988,638 | 384,858 | D: show line 1 in the form |
| SAYER KEVIN R President CEO and Chairman | 2024-03-12 | Sale 10b5-1 | −12,470 | $131.47 | $1,639,427 | 372,388 | D: show line 2 in the form |
| SAYER KEVIN R President CEO and Chairman | 2024-03-12 | Sale 10b5-1 | −14,993 | $132.43 | $1,985,571 | 357,395 | D: show line 3 in the form |
| SAYER KEVIN R President CEO and Chairman | 2024-03-12 | Sale 10b5-1 | −20,930 | $133.55 | $2,795,145 | 336,465 | D: show line 4 in the form |
| SAYER KEVIN R President CEO and Chairman | 2024-03-12 | Sale 10b5-1 | −2,939 | $134.07 | $394,023 | 333,526 | D: show line 5 in the form |
| Open-market sales · 81,007 sh · avg $133.36 · $10,802,803 | |||||||
Loading xslF345X05/edgardoc.xml…